( 02096.hk) | 21.86 | 3.12 | 1.62% (1.59%) | 上市时间2020-10-27股价12.73港币涨跌幅-2.45%成交金额1.24亿港币换手率0.38%市值326.93亿港币H股市值326.93亿港币总股本25.68亿H股本25.68亿每手股数1,000上市至今年化投资收益率4.74%港股通持仓占H股比例14.07% (47.58亿港币2026-07-21) 累计做空占H股比例1.33% (4.30亿港币2026-07-17) | |||
| 所属三级行业药品 (恒生) | 市盈率 | 27.47 | 市净率 | 2.47 | 股息率 | 1.38% (1.37%) | 恒生:医疗保健业药品及生物科技药品 |
| 所属指数指数纳入纳出 | |||||||
| 备注 (6): | 双击编辑备注 |
先声药业(02096) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 宋嘉桓 | Independent Non Executive Director | 2023-01-18 | -- | |
| 2 | 王熙 | Executive Director | 2023-01-18 | -- | |
| 3 | 宋瑞霖 | Independent Non Executive Director | 2019-11-19 | -- | |
| 4 | 唐任宏 | Executive Director | 2019-11-19 | -- | |
| 5 | 萬玉山 | Executive Director | 2019-11-19 | -- | |
| 6 | 汪建國 | Independent Non Executive Director | 2019-11-19 | -- | |
| 7 | 王新華 | Independent Non Executive Director - A/F | 2019-11-19 | -- | |
| 8 | 趙令歡 | Non Executive Director | 2019-11-19 | 2022-08-31 | |
| 9 | 張誠 | Executive Director | 2019-11-19 | 2021-03-31 | |
| 10 | 任晉生 | Executive Director | Chairman, CEO | 2015-11-30 | -- |